VANTRELA Trademark

Trademark Overview

On Friday, January 13, 2017, a trademark application was filed for VANTRELA with the United States Patent and Trademark Office. The USPTO has given the VANTRELA trademark a serial number of 87300733. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2019. This trademark is owned by Cephalon, Inc.. The VANTRELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
vantrela

General Information

Serial Number87300733
Word MarkVANTRELA
Filing DateFriday, January 13, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCephalon, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355
Party NameCephalon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355

Trademark Events

Event DateEvent Description
Monday, June 17, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 17, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 12, 2018EXTENSION 3 GRANTED
Monday, November 12, 2018EXTENSION 3 FILED
Monday, November 12, 2018TEAS EXTENSION RECEIVED
Saturday, May 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 10, 2018EXTENSION 2 GRANTED
Thursday, May 10, 2018EXTENSION 2 FILED
Thursday, May 10, 2018TEAS EXTENSION RECEIVED
Thursday, May 10, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2017EXTENSION 1 GRANTED
Thursday, November 9, 2017EXTENSION 1 FILED
Thursday, November 9, 2017TEAS EXTENSION RECEIVED
Tuesday, May 16, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2017ASSIGNED TO EXAMINER
Saturday, January 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

vantrela pain treatment preparations pharmaceutical